Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This trial phase I studies how well fingolimod works in preventing chemotherapy-induced nerve
pain (neuropathy) in patients with breast cancer who are taking paclitaxel. Fingolimod acts
by suppressing immune reactions in the brain. This study is being done to see if fingolimod
can reduce neuropathy caused by paclitaxel.